Results 211 to 220 of about 29,286 (231)

Dasatinib

Reactions Weekly
  +5 more sources

Dasatinib

Reactions Weekly, 2021
openaire   +2 more sources

Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects

Journal of Clinical Pharmacology, 2009
Timothy Eley, Shruti Agrawal, Richard Bertz   +2 more
exaly  

Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors

Cancer Treatment Reviews, 2010
Christopher J Logothetis
exaly  

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro

Breast Cancer Research and Treatment, 2007
Richard S Finn, Judy Dering, Charles Ginther   +2 more
exaly  

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis

British Journal of Cancer, 2009
R L Vessella, Eva Corey
exaly  

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Blood, 2012
Hagop Kantarjian, Jorge E Cortes, Michele Baccarani   +2 more
exaly  

Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer

International Journal of Molecular Sciences, 2020
Geul Bang, Seong-Jae Lee, Eun Hee Han
exaly  

Dasatinib induces autophagic cell death in human ovarian cancer

Cancer, 2010
Weiqun Mao, Zhen Lu, Robert C Bast
exaly  

Dasatinib

Reactions Weekly, 2017
  +4 more sources